About La Revas Pharma Private Limited
Data last updated:
La Revas Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the personal care and skincare products segment of the FMCG sector. It was incorporated on 10 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC313802. Its GSTIN is 19AADCL7015N1Z5 (West Bengal).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sandipan Chakraborty and Sujoy Mitra.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Shop No – 112 1st Floor Evershine Mall Pcs Mindspace Chincholi Bunder Po – Malad, Mumbai, Maharashtra, India – 400064.
As per the financials filed for FY 2023, the company reported a revenue of ₹63.75 Lakh, a growth of 17% compared to the previous year. For the same year it recorded a net loss of ₹7.28 Lakh (net margin -11.4%) and EBITDA of -₹6.21 Lakh (EBITDA margin -9.7%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years.
The company has about 6 employees on its provident fund (EPFO) records.
For more details, the company can be reached via its website larevaspharma.com.
Company details
Contact details
La Revas Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is larevaspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressShop No – 112 1st Floor Evershine Mall Pcs Mindspace Chincholi Bunder Po – Malad, Mumbai, Maharashtra, India – 400064
- IndustryFMCG, Personal Care & Skincare Products
To see the full contact details of La Revas Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of La Revas Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of La Revas Pharma Private Limited, buy the company report.
Financials of La Revas Pharma Private Limited
FY 2023 filings availableLa Revas Pharma Private Limited reported revenue of ₹63.75 Lakh (up 17% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 11% over three years, including 17% growth in the latest year. EBITDA fell 218% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹6.21 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹7.28 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -9.7% | ||||
| Net Profit Margin | -11.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of La Revas Pharma Private Limited, buy the company report.
Board of directors of La Revas Pharma Private Limited
La Revas Pharma has 5 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandipan Chakraborty | Director | 10 Sep 2018 | 8 Years 1 Months | Current |
| Sujoy Mitra | Director | 10 Sep 2018 | 8 Years 1 Months | Current |
| Biplab Nandi | Director | 10 Sep 2018 | 8 Years 1 Months | Current |
| Syed Asif Ali | Director | 10 Sep 2018 | 8 Years 1 Months | Current |
| Palas Paul | Director | 10 Sep 2018 | 8 Years 1 Months | Current |
Auditor
La Revas Pharma Private Limited is audited by R B ROY & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R B ROY & CO | FY 2021 | 322805E |
Shareholding
The shareholding of La Revas Pharma Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of La Revas Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving La Revas Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for La Revas Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
La Revas Pharma Private Limited has a workforce of 6 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
GST
La Revas Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AADCL7015N1Z5 | West Bengal | Active | 15 Nov 2018 |
To see the full GST registrations and return filing status of La Revas Pharma Private Limited, buy the company report.
Recent activity
La Revas Pharma Private Limited has 5 board changes on record since 2018: 5 appointments. The latest: Biplab Nandi was appointed as Director on 10 Sep 2018.
Frequently asked questions
La Revas Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in personal care and skincare products, within the FMCG industry. It was incorporated on 10 September 2018 (8+ years old) and is registered under CIN U74999MH2018PTC313802.
La Revas Pharma has 5 current directors:
- Sandipan Chakraborty - Director
- Sujoy Mitra - Director
- Biplab Nandi - Director
- Syed Asif Ali - Director
- Palas Paul - Director
The latest financial statements of La Revas Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2019 are in the company report.
The GSTIN of La Revas Pharma is 19AADCL7015N1Z5, registered in West Bengal.
The CIN (Corporate Identification Number) of La Revas Pharma is U74999MH2018PTC313802. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
La Revas Pharma was incorporated on 10 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Biplab Nandi was appointed as Director on 10 Sep 2018. Palas Paul was appointed as Director on 10 Sep 2018. Sandipan Chakraborty was appointed as Director on 10 Sep 2018. La Revas Pharma has 5 board changes on record in total.
La Revas Pharma can be reached through the website larevaspharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of La Revas Pharma is at Shop No – 112 1st Floor Evershine Mall Pcs Mindspace Chincholi Bunder Po – Malad, Mumbai, Maharashtra, India – 400064.
La Revas Pharma operates in the FMCG industry, in the personal care and skincare products segment.